POTO, REMO
 Distribuzione geografica
Continente #
AS - Asia 1.905
EU - Europa 1.144
NA - Nord America 985
SA - Sud America 233
AF - Africa 44
OC - Oceania 3
Totale 4.314
Nazione #
SG - Singapore 1.008
US - Stati Uniti d'America 927
RU - Federazione Russa 609
CN - Cina 458
IT - Italia 201
BR - Brasile 190
HK - Hong Kong 164
VN - Vietnam 119
DE - Germania 115
FI - Finlandia 43
KR - Corea 39
CA - Canada 34
FR - Francia 34
IN - India 32
GB - Regno Unito 31
NL - Olanda 22
AR - Argentina 17
BD - Bangladesh 17
MX - Messico 16
BG - Bulgaria 13
IE - Irlanda 12
JP - Giappone 12
AT - Austria 11
CI - Costa d'Avorio 11
UA - Ucraina 11
ID - Indonesia 9
IQ - Iraq 9
ZA - Sudafrica 9
SE - Svezia 8
VE - Venezuela 8
ES - Italia 7
PL - Polonia 7
CO - Colombia 6
EC - Ecuador 6
PK - Pakistan 6
MA - Marocco 5
BE - Belgio 4
TR - Turchia 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
GR - Grecia 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BY - Bielorussia 2
DZ - Algeria 2
EG - Egitto 2
GY - Guiana 2
PA - Panama 2
RO - Romania 2
UG - Uganda 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
MD - Moldavia 1
MR - Mauritania 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
YT - Mayotte 1
Totale 4.314
Città #
Singapore 494
Hefei 227
Moscow 164
Hong Kong 162
Ashburn 123
Beijing 102
Chandler 75
Naples 64
Santa Clara 57
Los Angeles 41
Ho Chi Minh City 40
Munich 39
Seoul 39
Hanoi 25
Redondo Beach 23
Turku 23
Lawrence 22
San Jose 22
New York 21
Buffalo 20
São Paulo 20
Boston 19
Menlo Park 19
Millbury 18
Dallas 16
Frankfurt am Main 16
Seattle 16
Wilmington 13
Mexico City 12
Napoli 12
Sofia 12
Amsterdam 11
Helsinki 11
Tokyo 11
Des Moines 10
Krefeld 10
Orem 10
Rome 10
Chicago 9
Kochi 9
Lappeenranta 9
Pune 9
Düsseldorf 8
Stockholm 8
Toronto 8
London 7
Milan 7
Montreal 7
Atlanta 6
Bari 6
Denver 6
Guangzhou 6
Houston 6
Johannesburg 6
Manchester 6
Phoenix 6
Rio de Janeiro 6
Vancouver 6
Warsaw 6
Brooklyn 5
Falkenstein 5
Formia 5
Ottawa 5
Padova 5
Poplar 5
The Dalles 5
Woodbridge 5
Ankara 4
Bexley 4
Brasília 4
Council Bluffs 4
Dhaka 4
Dong Ket 4
Gravina in Puglia 4
Lahore 4
Ninh Bình 4
Rottweil 4
San Mateo 4
St Petersburg 4
Tianjin 4
Tramonti 4
Albanella 3
Belo Horizonte 3
Biên Hòa 3
Boardman 3
Bogotá 3
Brussels 3
Buenos Aires 3
Caserta 3
Curitiba 3
Da Nang 3
Douliu 3
Dublin 3
Erbil 3
Fairfield 3
Georgetown 3
Ha Long 3
Haiphong 3
Jundiaí 3
Lauterbourg 3
Totale 2.329
Nome #
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages 143
The immunology of switching biologics in severe eosinophilic asthma patients 121
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 119
The emerging role of T follicular helper (TFH) cells in aging: Influence on the immune frailty. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE) 114
Oxidative stress in anticancer therapies-related cardiac dysfunction 114
Human Lung Mast Cells: Therapeutic Implications in Asthma 110
Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency 109
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE) 107
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID) 99
The broad spectrum of cardiotoxicities from immunotherapies 99
Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells 99
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 99
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. (VARRICCHI ULTIMO AUTORE E AUTORE CORRISPONDENTE) 95
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series 94
TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD 92
Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer 92
Is There a Role for Basophils in Cancer? 92
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies 89
Neutrophil Extracellular Traps, Angiogenesis and Cancer 89
IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells 89
Neutrophil Extracellular Traps in Asthma: Friends or Foes? 88
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 88
Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE) 87
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study 86
Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase 86
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma 85
Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma 85
Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction 84
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study 82
Differential Effects of Alarmins on Human and Mouse Basophils 82
Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions 80
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis 76
Pembrolizumab associated hypereosinophilia in locally advanced triple-negative breast cancer 76
IL-3 in the development and function of basophils 76
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells 74
Basophils beyond allergic and parasitic diseases 70
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events 70
Is there a role for microbiome-based approach in common variable immunodeficiency? 66
Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency? 65
Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli 65
Basophils from allergy to cancer 62
Mast cells: a novel therapeutic avenue for cardiovascular diseases? 61
TL1A: a novel alarmin in airway, intestinal, and autoimmune disorders 60
Unleashing the power of formyl peptide receptor 2 in cardiovascular disease 59
Biologics and airway remodeling in severe asthma 58
The Role of Gut Microbiota and Leaky Gut in the Pathogenesis of Food Allergy 53
Can FeNO be a biomarker in the post-COVID-19 patients monitoring? 53
Gender dimorphism in IgA subclasses in T2-high asthma 53
Advancing precision medicine for asthma by focusing on type 2 cytokines and alarmins 52
Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins 50
T follicular helper cells (TFH): From physiological to pathological aging 46
Biologics and airway remodeling in asthma: early, late, and potential preventive effects 46
The Intriguing Role of Short-Form TSLP by Zeitvogel et al 41
Histamine as a mediator of cross-talk between human lung mast cells and macrophages 37
Dupilumab and Blood Eosinophilia: A Disease-Specific Phenomenon? 25
TSLP: contrasting roles in cancer 19
Effects of Advanced Glycation End Products (AGEs) on Human Lung Macrophages: Implications for Pulmonary Inflammation 14
Totale 4.425
Categoria #
all - tutte 14.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 11 3 2 7 4 5
2021/2022209 3 8 15 13 10 0 2 13 0 14 56 75
2022/2023261 28 11 9 5 33 27 26 40 31 14 24 13
2023/2024254 5 35 33 26 9 37 14 27 9 11 30 18
2024/20251.481 68 65 1 7 24 92 164 106 91 146 529 188
2025/20262.156 357 322 433 386 520 108 30 0 0 0 0 0
Totale 4.425